Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV in Korea: 24-Month Data from BICSTaR
Infection & Chemotherapy · 2025 · 57 (3) · 424
DOI: 10.3947/ic.2025.0061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection & Chemotherapy, 2025. Verfasst von Yeon-Sook Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.
- Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
- Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.
- Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
- Gilead Sciences, Inc., Foster City, CA, USA.
ORCID-Profile: Yeon-Sook Kim, Jun Yong Choi, Dae Won Park, Shin-Woo Kim, Tae Hyong Kim, Julie Ryu, Rebecca Harrison, Jeong-A Lee, Flora Park, Sun Hee Lee
Förderung
- Gilead Sciences
Zitieren
APA
Kim, Y. S., Choi, J. Y., Park, D. W., Kim, S. W., Kim, T. H., Ryu, J., Harrison, R., Lee, J. A., Park, F., & Lee, S. H. (2025). Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV in Korea: 24-Month Data from BICSTaR. Infection & Chemotherapy, 57(3), 424. https://doi.org/10.3947/ic.2025.0061
Vancouver
Kim YS, Choi JY, Park DW, Kim SW, Kim TH, Ryu J, et al. Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV in Korea: 24-Month Data from BICSTaR. Infection & Chemotherapy. 2025;57(3):424. doi:10.3947/ic.2025.0061
BibTeX
@article{Kim2025,
author = {Kim, Yeon-Sook and Choi, Jun Yong and Park, Dae Won and Kim, Shin-Woo and Kim, Tae Hyong and Ryu, Julie and Harrison, Rebecca and Lee, Jeong-A and Park, Flora and Lee, Sun Hee},
title = {Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV in Korea: 24-Month Data from BICSTaR},
journal = {Infection & Chemotherapy},
year = {2025},
volume = {57},
number = {3},
pages = {424},
doi = {10.3947/ic.2025.0061}
}
EUVIMED